Literature DB >> 8608253

Protection from lethal malaria in transgenic mice expressing sickle hemoglobin.

A T Hood1, M E Fabry, F Costantini, R L Nagel, H L Shear.   

Abstract

Previous studies from our laboratories have shown that transgenic mice expressing high levels of beta S globin are well-protected from Plasmodium chabaudi adami and partially protected against P berghei (Shear et al, Blood 81:222, 1993). We have now infected transgenic mice expressing low (39%), intermediate (57%), and high (75%) levels of beta S with the virulent strain of P yoelii (17XL) that appears to cause cerebral malaria. We find that the level of protection in these three groups of mice correlates positively with the level of beta S chain expression in the mice. Seven of nine mice expressing the high level of beta S recovered from infection, as did 7 of 9 mice expressing the intermediate level of beta S. Control mice and mice expressing the lower level of beta S all succumbed to infection. In mice expressing high and intermediate levels of beta S, parasites were found almost exclusively in reticulocytes during recovery, suggesting that mature red blood cells expressing beta S are more resistant than reticulocytes. These studies confirm epidemiologic data and offer insight into the mechanism of protection of sickle trait individuals against falciparum malaria.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 8608253

Source DB:  PubMed          Journal:  Blood        ISSN: 0006-4971            Impact factor:   22.113


  9 in total

1.  Impact of sickle cell trait on the thrombotic risk associated with non-O blood groups in northern Nigeria.

Authors:  Sagir G Ahmed; Modu B Kagu; Umma A Ibrahim; Audu A Bukar
Journal:  Blood Transfus       Date:  2015-05-27       Impact factor: 3.443

Review 2.  Host genetics in malaria: lessons from mouse studies.

Authors:  Hong Ming Huang; Brendan J McMorran; Simon J Foote; Gaetan Burgio
Journal:  Mamm Genome       Date:  2018-03-28       Impact factor: 2.957

3.  The role of infection in the pathogenesis of vaso-occlusive crisis in patients with sickle cell disease.

Authors:  Sagir G Ahmed
Journal:  Mediterr J Hematol Infect Dis       Date:  2011-07-08       Impact factor: 2.576

4.  Mechanistic Studies of the Negative Epistatic Malaria-protective Interaction Between Sickle Cell Trait and α+thalassemia.

Authors:  D Herbert Opi; Lucy B Ochola; Metrine Tendwa; Bethsheba R Siddondo; Harold Ocholla; Harry Fanjo; Ashfaq Ghumra; David J P Ferguson; J Alexandra Rowe; Thomas N Williams
Journal:  EBioMedicine       Date:  2014-11-01       Impact factor: 8.143

5.  Hematological parameters in sickle cell anemia patients with and without priapism.

Authors:  Sagir G Ahmed; Umma A Ibrahim; Abba W Hassan
Journal:  Ann Saudi Med       Date:  2006 Nov-Dec       Impact factor: 1.526

Review 6.  The malaria-infected red blood cell: structural and functional changes.

Authors:  B M Cooke; N Mohandas; R L Coppel
Journal:  Adv Parasitol       Date:  2001       Impact factor: 3.870

7.  Sickle cell protection from malaria.

Authors:  Sandro Eridani
Journal:  Hematol Rep       Date:  2011-11-04

8.  High Dietary Folate in Mice Alters Immune Response and Reduces Survival after Malarial Infection.

Authors:  Danielle N Meadows; Renata H Bahous; Ana F Best; Rima Rozen
Journal:  PLoS One       Date:  2015-11-24       Impact factor: 3.240

9.  Females of HbAS genotype have reduced concentration of the malaria protective deoxyhemoglobin S than males.

Authors:  John N Waitumbi; Carolyne M Kifude; Carol W Hunja; Bernhards R Ogutu
Journal:  PLoS One       Date:  2018-09-11       Impact factor: 3.240

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.